Haw Par Corporation reports profit of 122.0 mil for 1HFY2024, 17.1 percent higher y-o-y - Yahoo Finance
| HAWPY Stock | USD 28.64 0.00 0.00% |
Slightly above 56% of Haw Par's investor base is looking to short. The analysis of overall sentiment of trading Haw Par pink sheet suggests that many investors are alarmed at this time. Haw Par's investing sentiment can be driven by a variety of factors including economic data, Haw Par's earnings reports, geopolitical events, and overall market trends.
Haw |
Haw Par Corporation reports profit of 122.0 mil for 1HFY2024, 17.1 percent higher y-o-y Yahoo Finance
Read at news.google.com
 |
Haw Par Fundamental Analysis
We analyze Haw Par's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Haw Par using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Haw Par based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Haw Par is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Haw Par Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Haw Par pink sheet to make a market-neutral strategy. Peer analysis of Haw Par could also be used in its relative valuation, which is a method of valuing Haw Par by comparing valuation metrics with similar companies.
Peers
Haw Par Related Equities
| MRK | Merck | 1.50 | ||||
| RHHBY | Roche Holding | 1.12 | ||||
| BMY | Bristol Myers | 0.65 | ||||
| ABBV | AbbVie | 0.68 | ||||
| AZN | AstraZeneca PLC | 0.68 | ||||
| GSK | GlaxoSmithKline PLC | 0.81 | ||||
| PFE | Pfizer | 1.33 | ||||
| LLY | Eli Lilly | 1.72 | ||||
| JNJ | Johnson Johnson | 1.74 | ||||
| SNY | Sanofi ADR | 2.08 |
Additional Tools for Haw Pink Sheet Analysis
When running Haw Par's price analysis, check to measure Haw Par's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw Par is operating at the current time. Most of Haw Par's value examination focuses on studying past and present price action to predict the probability of Haw Par's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw Par's price. Additionally, you may evaluate how the addition of Haw Par to your portfolios can decrease your overall portfolio volatility.